US

Uma Shankar Maurya

Active Director Director DIN 09516771
DIN 09516771 First appointment Feb 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value •••• Premium profile

About Uma Shankar Maurya

Data last updated:

Uma Shankar Maurya is a Director at Codon Pharma Private Limited (since 2022). The company operates in Healthcare. Codon Pharma Private Limited reported revenue of ₹52,880 (FY 2025).

DIN 09516771
Primary Designation Director
Industry Healthcare
First Appointment 23 Feb 2022
Oldest Company Age 4 yrs
Largest company Codon Pharma Private Limited · ₹52,880 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Codon Pharma Private Limited U24231UP2022PTC159974
Director23 Feb 20222022₹52,880 (FY 2025)Active

Board colleagues of Uma Shankar Maurya

NameDINCompanyDesignation
Rashmi Jaiswal09516770Codon Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Codon Pharma Private Limited
Premium access

Shareholding and investment profile for Uma Shankar Maurya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Uma Shankar Maurya

Uma Shankar Maurya currently holds 1 directorship: Codon Pharma Private Limited (Director, since 23 Feb 2022, revenue ₹52,880 (FY 2025)).

Uma Shankar Maurya was first appointed on 23 Feb 2022 as Director at Codon Pharma Private Limited.

The current boards of Uma Shankar Maurya's companies include Rashmi Jaiswal (Codon Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available